The use of artificial intelligence techniques in medical decision support systems is becoming more commonplace. By incorporating a method to represent expert knowledge, such systems can aid the user in aspects such as disease diagnosis and treatment planning. This paper reports on the first part of a project addressing the diagnosis of individuals with dementia. We discuss two systems: DemNet and PathNet; developed to aid accurate diagnosis both of the presence of dementia, and the pathology of the disease.
INTRODUCTION
The assessment and correct management of individuals with dementia is complex, and requires a high level of expertise. The first stage of our research has focused on the development of a disease diagnosis system. The system can be viewed as two parts: DemNet which aids a clinical decision maker in diagnosing the likelihood of dementia; and PathNet which provides an indication of the possible disease(s) causing the dementia. Both systems utilise the technique of Bayesian Belief Networks (BBNs) to provide probabilistic information pertaining to the presence of dementia and likely pathologies.
In this paper, we begin by providing the reader with a brief description of the dementia syndrome, common pathologies, and current ways in which the disease is diagnosed. The two prototype systems developed, DemNet and PathNet are then discussed in detail. The paper concludes with a report on preliminary findings and the potential for future work.
DEMENTIA

About Dementia
Dementia is a term used to describe a syndrome caused by a variety of brain disorders that have in common a loss of brain function, which is usually progressive and eventually severe (Alzheimer's Society, 2005) . Symptoms of dementia may include: loss of memory, confusion and problems with language, executive function, and social function. The clinical decision support system (CDSS) we have developed focuses on providing support in diagnosing dementia and distinguishing between the four most common dementias of old age: Alzheimer's disease (AD), Vascular dementia (VaD), Dementia with Lewy bodies (DLB), and Fronto-temporal dementia (FTD).
The current method adopted for diagnosing dementia involves evaluation of the clinical syndrome based on history and examination, supported by screening investigations, and, where appropriate, additional more specialised investigations. In progressive degenerative dementias, during the very early stages cognitive deficits are usually subtle and their manifestations, though representing change from pre-morbid function in an individual, may remain within the normal range for the general population. This presents considerable challenges to early diagnosis. However, early diagnosis and an understanding of the underlying pathologies is of value in planning treatment and, in some cases, initiating specific drug intervention.
Systems to aid in medical decision making, and in particular, disease diagnosis were introduced in the medical field over 25 years ago. Despite their potential usefulness in helping to provide early and accurate diagnosis, relatively few are in general use (Kaplan, 2001 ). This can be attributed to the difficulties of integrating such systems into a clinical setting; an environment of complex systems consisting of involved algorithms, procedures, and protocols. By addressing this complexity and our continued interaction with those who would potentially use the clinical decision support system (CDSS), we hope to ensure our system is adopted and perceived as a useful aid in the diagnosis procedure.
Disease diagnosis systems
Many different operational research and artificial intelligence techniques have been adopted by CDSSs.
Such techniques include the use of mathematical models (Werner and Fogarty, 2001 ), neural networks (Dybowski et al., 1996) and more recently, optimisation techniques (De Toro et al., 2003) . Further details of the use of such techniques are detailed in Oteniya et al (2005) .
CDSSs have also been developed that address the specific area of dementia diagnosis. García-Pérez et al. (1998) use data mining and neural network techniques and Mani et al (1997) apply decision-trees and rule-based approaches to differentiate between Alzheimer's disease and Vascular dementia.
Our CDSSs extend such systems by providing a means of identifying the presence of dementia and the likelihood of underlying pathologies. DemNet provides the means by which the likelihood of dementia is predicted, and PathNet suggests the disease type(s) causing the dementia. Both softwares use Bayesian Belief Networks (BBNs) to calculate their predictions of the presence of the dementia syndrome and causal diseases respectively.
DEMNET
DemNet uses a probabilistic model of dementia diagnosis that incorporates patient history features and physical findings. In an attempt to optimise user friendliness and utility in a busy primary care setting, the model seeks to use as numerically few and as simple to use parameters as is consistent with reasonably high diagnostic accuracy. DemNet is described in terms of two components: the user interface and underlying BBN. Each node of the BBN relates to a question asked of the user. The more answers to questions the user can provide, the more accurate the system in diagnosing the presence of dementia.
DemNet is designed to be used by clinical practice nurses, who are involved in the primary level assessment of patients suspected of having dementia. In an attempt to ensure that the system can be easily integrated into current working practices, the design of the system has been accompanied by frequent discussion with experts in the field of dementia diagnosis, and potential users of the system. For further details relating to the current practices involved in dementia diagnosis, the reader is directed to Oteniya et al (2005) .
The Bayesian Belief Network
The underlying DemNet BBN is given in Figure 1 . In the model, the nodes on the periphery of the network collect evidence relating to: the individual's current functioning, global severity of cognitive impairment, individual's age, duration of impairment, and whether clear progression is identifiable. With each piece of evidence presented, the model recalculates the posterior probability of the related child nodes. For example, in our model, the state of node 4 (current functioning) combined with evidence presented to nodes 3, 5, and 7 will cause the recalculation of posterior probabilities for child nodes 6 and 11. This implies that information given regarding the level to which cognition is impaired (node 3) and the degree to which subtle functioning is effected (node 5), combined with the state of current functioning, influences a patient's global severity (node 6) and ultimately the likelihood of the patient having dementia (node 11). The network also incorporates the level of influence which data has on increasing a related node's probability. In Figure 1 , we can see that a subset of information has been provided about a given patient, namely, information pertaining to Global DADL, Cognitive Impairment, Subtle Functioning, Duration, and Age. Given the information provided, we can see that this patient has a probability of 0.7 (rounded to 1 d.p) of having dementia. 
User Interface
An intuitive user interface guides the user through a series of questions representative of each node in the BBN. This interface is depicted in Figure 2 .
Figure2: DemNet Interface
The interface is divided into 3 areas, namely the model pane, diagnostic pane, and results pane. The model pane displays the underlying DemNet model which can be helpful to the user in identifying which pieces of data they have provided (nodes with evidence are marked in dark grey) and some notion of how each piece of data relates to the diagnosis given. The diagnostic pane displays the question associated with a selected diagnostic node. Each node has a number of possible states. Each of these states relate to possible answers to the diagnostic questions. The user is therefore restricted in the response they give by choosing the appropriate answer from a drop down menu. The results pane for DemNet shows 3 sets of results relating to current functioning, global severity, and dementia. The first two set of bars in the results pane relate to nodes in the model that are crucial to determining whether dementia is present, and are nodes which rely heavily on the answers/evidence given to other nodes. The three bars associated with Current Functioning and the three bars associated with Global Severity are representative of the 3 states possible for these nodes.
PATHNET
PathNet is an extension of DemNet for use within primary care by the same users as DemNet, likely to be primary care nurses in support of the diagnosing physician. The system allows the decision maker to identify the underlying pathologies of a given case of dementia. A number of different pathologies can lead to the syndrome of dementia, either singly, or in combination. It is the four most common dementias of later life: Alzheimer's disease, Vascular dementia, dementia with Lewy bodies and Fronto-temporal dementia that PathNet aims to identify.
As with DemNet, the system can be divided into the user interface and underlying BBN. As the dementia syndrome may be caused by multiple co-existing pathologies, we have designed our model such that it is capable of identifying the likelihood of different types of dementia, either singularly, or, as is often the case, coexistent with other dementia diseases. In addition, if dementia is suspected, but none of the four most common pathologies can be identified, the system indicates the presence of dementia (other), that is, a form of dementia not identified by the system. The PathNet interface is identical in layout to the DemNet Interface but has one main difference in the results pane. This incorporates information relating to the likelihood of the different dementia pathologies. This is shown in Figure 3 . As can be seen from Figure 3 , the user is provided with a visual representation of the probability distribution across each of the diseases.
CURRENT FINDINGS AND FUTURE WORK
Evaluation of DemNet
We are in the process of investigating different possibilities for conducting a formal evaluation of the software developed to date. This is anticipated to be some form of clinical trial. Throughout the development of DemNet, we have been in regular consultation with a domain expert who provided input regarding the structure of the system, design of the model, and domain data. We have also arranged a workshop to demonstrate DemNet to further expert practitioners working in the field of dementia diagnosis.
As a less formal method of analysis, the system will be evaluated by 3 rd year undergraduate computing science students undertaking the Information Systems unit. Results from this work will be published later in the year.
Refinement of PathNet
The PathNet BBN is in the very early stages of development and as such needs to be validated to ensure the results provided are accurate. Over the next 3 months, extensive testing and refinement of the system will be undertaken.
Inducing the network
Current work is focusing on collecting data from clinical practitioners conducting dementia diagnosis. We hope to build up a sufficient body of data to be able to induce the structure and parameters of a BBN, and ultimately compare the structure and diagnostic accuracy with the initially hand-crafted model; providing insight into the potential advantages and disadvantages of each approach for building BBNs.
CONCLUDING COMMENTS
Although this research is still in its preliminary stages, we feel confident that the system developed has great potential in aiding in dementia diagnosis. Through presentations and informal discussions, we have been able to gain some initial feedback from practitioners involved in this area. This feedback has been extremely enthusiastic and encouraging.
Further details of the project can be found in Oteniya et al. [2005a] and on the project website: www.cs.stir.ac.uk/~lot/dotpi/.
